Giant Cell Arteritis
Last Posted: Apr 10, 2021
- Myeloproliferative neoplasms and clonal hematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.
Papo Matthias, et al. Rheumatology (Oxford, England) 2021 4
- The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña Diana, et al. Clinical and experimental rheumatology 2021 3
- Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
Thomsen Hauke et al. Scientific reports 2020 10(1) 20887
- Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.
Prieto-Peña Diana, et al. Seminars in arthritis and rheumatism 2020 7 (5) 897-901
- Colour Doppler ultrasound of temporal arteries for the diagnosis of giant cell arteritis: a multicentre deep learning study.
Roncato Christophe et al. Clinical and experimental rheumatology 38 Suppl 124(2) 120-125
- Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis.
López-Mejías Raquel, et al. Clinical and experimental rheumatology 2020 3
- A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.
González-Serna David, et al. PloS one 2018 0 (12) e0209343
- PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis.
Lester Susan, et al. RMD open 2016 0 (1) e000246
- Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach.
Tizaoui Kalthoum, et al. Journal of clinical medicine 2019 3 (3)
- Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study.
Cai Tianxi, et al. JAMA cardiology 2018 8
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.